1999
DOI: 10.1006/abio.1999.4267
|View full text |Cite
|
Sign up to set email alerts
|

Simultaneous Analysis of Hemoglobin Adducts of Acrylamide and Glycidamide by Gas Chromatography–Mass Spectrometry

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
34
0

Year Published

2000
2000
2017
2017

Publication Types

Select...
4
3

Relationship

0
7

Authors

Journals

citations
Cited by 60 publications
(34 citation statements)
references
References 14 publications
0
34
0
Order By: Relevance
“…The assumption that GA is the genotoxic agent in AA exposure implies that it is important also to measure the ratio between internal doses of AA and GA. The data so far published indicate that the ratio between the adduct levels to N-terminal valine of GA and AA is about 1:1 [11,45], however with a lower value obtained by Licea-Perez et al [13].…”
mentioning
confidence: 71%
See 3 more Smart Citations
“…The assumption that GA is the genotoxic agent in AA exposure implies that it is important also to measure the ratio between internal doses of AA and GA. The data so far published indicate that the ratio between the adduct levels to N-terminal valine of GA and AA is about 1:1 [11,45], however with a lower value obtained by Licea-Perez et al [13].…”
mentioning
confidence: 71%
“…All previous data on the background level of the Hb adduct from AA [12][13][14][15][45][46], except for the study by Schettgen et al [47], came from the same laboratory as in the present study, using the same instruments and standards for quantification etc. In these published studies of altogether about 50 non-smoking individuals the adduct level varies between 0.02 and 0.07 nmol/g Hb.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…Hemoglobin adducts of acrylamide and glycidamide, its primary metabolite, were successfully developed as biomarkers of acrylamide exposure and used to investigate the health effects of this chemical on humans and animals (16)(17)(18)(19)(20). Assessing acrylamide exposure using these biomarkers provides comprehensive information about the amount of acrylamide that has entered a person's body over the previous 2 to 3 months, even when the actual exposure event has passed.…”
Section: Introductionmentioning
confidence: 99%